Sarepta Therapeutics (SRPT) Inventory Average (2016 - 2026)

Sarepta Therapeutics' Inventory Average history runs 11 years deep, the most recent figure standing at $957.9 million for Q1 2026.

• In Q1 2026, Inventory Average rose 13.27% year-over-year to $957.9 million; the TTM figure through Mar 2026 stood at $957.9 million (up 13.27% YoY), while the FY2025 annual figure was $832.4 million, up 55.17% from the prior year.
• Inventory Average was $957.9 million for Q1 2026 at Sarepta Therapeutics, down from $996.0 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $1.0 billion in Q3 2025 to a low of $192.6 million in Q1 2022.
• Historically, Inventory Average has averaged $501.5 million across 5 years, with a median of $348.2 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Inventory Average decreased 22.96% in 2022, then surged 142.88% in 2025.
• A 5-year view of Inventory Average shows it stood at $212.6 million in 2022, then jumped by 33.33% to $283.4 million in 2023, then soared by 132.13% to $657.9 million in 2024, then soared by 51.37% to $996.0 million in 2025, then decreased by 3.82% to $957.9 million in 2026.
• The last three Inventory Average figures came in at $957.9 million (Q1 2026), $996.0 million (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.